News and Updates

Discover why advanced IRT supply management is essential for biotech success. Learn how to optimize clinical trial logistics and ensure patient safety.

Biohaven pushes BHV-7000 into pivotal trials despite unresolved FDA queries. Learn the implications for this epilepsy treatment and its regulatory path.

Biohaven moves BHV-7000 into pivotal trials for epilepsy despite pending regulatory questions. Discover the risks and clinical implications of this move.

Sionna Therapeutics begins a Phase 2a trial testing the combination of SION-451 and SION-2222 to improve CFTR protein function in Cystic Fibrosis patients.

Piramal Pharma addresses seven FDA observations at its UK Morpeth facility. Learn how the company is implementing CAPA to meet strict cGMP standards.

Cere-Calm trials are advancing the future of neuro-modulation. Explore the latest updates on this clinical progress and its impact on neurological care.

Explore how Rybrevant is redefining standard care for EGFR-mutated lung cancer through bispecific antibody innovation and improved survival outcomes.

New data from ESCRS 2026 confirms the enVista Envy IOL delivers consistent real-world outcomes, maintaining high visual quality despite minor refractive error.

Expert analysis reveals why traditional trial designs are failing rare kidney cancer patients and how adaptive research is changing the future of RCC.

Eli Lilly discontinues an early-stage obesity drug candidate after it failed to meet rigorous clinical efficacy standards for metabolic treatment.